This may be due to the fact that the nature of acute inflammation in ACS is amplified by HSUA-induced oxidative stress and NLRP3 inflammasome activity, and these effects could cause inconsistent early outcomes like faster myocardial ischemia or stroke (4, 5). The gene discussed is NLRP3; the disease is Stroke.